- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/195 - Radicals derived from nitrogen analogues of carboxylic acids
Patent holdings for IPC class C07D 295/195
Total number of patents in this class: 89
10-year publication summary
9
|
9
|
10
|
8
|
9
|
2
|
5
|
4
|
7
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The General Hospital Corporation | 4650 |
6 |
Reata Pharmaceuticals Holdings, LLC | 46 |
6 |
Massachusetts Institute of Technology | 9913 |
5 |
The Broad Institute, Inc. | 1709 |
5 |
Concentric Analgesics, Inc. | 24 |
4 |
Syngenta Participations AG | 3032 |
3 |
President and Fellows of Harvard College | 5913 |
3 |
Rhizen Pharmaceuticals AG | 56 |
3 |
Bristol-myers Squibb Company | 4863 |
2 |
Bayer Cropscience AG | 2138 |
2 |
Ricoh Company, Ltd. | 13216 |
2 |
University of Florida Research Foundation, Inc. | 3958 |
2 |
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences | 70 |
2 |
Northeastern University | 1136 |
2 |
Novira Therapeutics, Inc. | 32 |
2 |
Oryzon Genomics S.A. | 105 |
2 |
Recordati Industria Chimica e Farmaceutica S.p.A. | 56 |
2 |
Corteva Agriscience LLC | 2681 |
2 |
Wisorig Technologies Pte. Limited | 10 |
2 |
The Regents of the University of California | 19517 |
1 |
Other owners | 31 |